[{"address1": "1150 Veterans Boulevard", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "925 407 1049", "website": "https://www.nkartatx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. The company's lead product candidate is NKX019, a chimeric antigen receptor-natural killer (CAR NK) targeting the CD19 antigen, which is in Phase 1 clinical trial for the treatment of lupus nephritis; systemic sclerosis; idiopathic inflammatory myopathy; and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, as well as for systemic lupus erythematosus and myasthenia gravis. It has a research collaboration agreement with CRISPR Therapeutics AG. Nkarta, Inc. was incorporated in 2015 and is based in South San Francisco, California.", "fullTimeEmployees": 105, "companyOfficers": [{"maxAge": 1, "name": "Mr. Paul J. Hastings", "age": 65, "title": "CEO & Director", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 979777, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Nadir  Mahmood Ph.D.", "age": 46, "title": "President and Principal Accounting & Financial Officer", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 640919, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Shawn  Rose M.D., Ph.D.", "title": "Chief Medical Officer and Head of Research & Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 6, "overallRisk": 7, "governanceEpochDate": 1769904000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.36, "open": 2.35, "dayLow": 2.28, "dayHigh": 2.36, "regularMarketPreviousClose": 2.36, "regularMarketOpen": 2.35, "regularMarketDayLow": 2.28, "regularMarketDayHigh": 2.36, "payoutRatio": 0.0, "beta": 0.521, "forwardPE": -1.774116, "volume": 531274, "regularMarketVolume": 531274, "averageVolume": 734783, "averageVolume10days": 682720, "averageDailyVolume10Day": 682720, "bid": 2.29, "ask": 2.37, "bidSize": 1, "askSize": 1, "marketCap": 165498752, "fiftyTwoWeekLow": 1.31, "fiftyTwoWeekHigh": 2.74, "allTimeHigh": 79.16, "allTimeLow": 1.28, "fiftyDayAverage": 2.0074, "twoHundredDayAverage": 2.0022, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -40198236, "profitMargins": 0.0, "floatShares": 53154935, "sharesOutstanding": 71029512, "sharesShort": 6538944, "sharesShortPriorMonth": 6020166, "sharesShortPreviousMonthDate": 1767139200, "dateShortInterest": 1769731200, "sharesPercentSharesOut": 0.0921, "heldPercentInsiders": 0.00538, "heldPercentInstitutions": 0.82846, "shortRatio": 7.48, "shortPercentOfFloat": 0.12189999, "impliedSharesOutstanding": 71029512, "bookValue": 4.758, "priceToBook": 0.48970154, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -102610000, "trailingEps": -1.38, "forwardEps": -1.31333, "enterpriseToEbitda": 0.376, "52WeekChange": -0.13215858, "SandP52WeekChange": 0.11527538, "quoteType": "EQUITY", "currentPrice": 2.33, "targetHighPrice": 25.0, "targetLowPrice": 8.0, "targetMeanPrice": 14.0, "targetMedianPrice": 11.0, "recommendationMean": 1.42857, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 282331008, "totalCashPerShare": 3.975, "ebitda": -106944000, "totalDebt": 76634000, "quickRatio": 14.98, "currentRatio": 15.235, "debtToEquity": 22.679, "returnOnAssets": -0.15138, "returnOnEquity": -0.26694, "freeCashflow": -57524000, "operatingCashflow": -91803000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "NKTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "earningsTimestampStart": 1774990800, "earningsTimestampEnd": 1774990800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.38, "epsForward": -1.31333, "epsCurrentYear": -1.34333, "priceEpsCurrentYear": -1.7344955, "fiftyDayAverageChange": 0.3225999, "fiftyDayAverageChangePercent": 0.16070533, "twoHundredDayAverageChange": 0.32780004, "twoHundredDayAverageChangePercent": 0.16371994, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-07-10", "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1594387800000, "postMarketChangePercent": 0.85836834, "postMarketPrice": 2.35, "postMarketChange": 0.01999998, "regularMarketChange": -0.03, "regularMarketDayRange": "2.28 - 2.36", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 734783, "fiftyTwoWeekLowChange": 1.02, "fiftyTwoWeekLowChangePercent": 0.77862597, "fiftyTwoWeekRange": "1.31 - 2.74", "fiftyTwoWeekHighChange": -0.4100001, "fiftyTwoWeekHighChangePercent": -0.14963506, "fiftyTwoWeekChangePercent": -13.2158575, "shortName": "Nkarta, Inc.", "longName": "Nkarta, Inc.", "corporateActions": [], "postMarketTime": 1771622182, "regularMarketTime": 1771621201, "exchange": "NMS", "messageBoardId": "finmb_544531597", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -1.27119, "regularMarketPrice": 2.33, "displayName": "Nkarta", "trailingPegRatio": null, "__fetch_time": "2026-02-21"}]